ClearPoint Neuro
CLPT
56 hedge funds and large institutions have $39.6M invested in ClearPoint Neuro in 2022 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 9 closing their positions.
80% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 10
67% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 9
12% more call options, than puts
Call options by funds: $2.1M | Put options by funds: $1.87M
12% more funds holding
Funds holding: 50 → 56 (+6)
0.93% more ownership
Funds ownership: 14.69% → 15.62% (+0.93%)
13% less capital invested
Capital invested by funds: $45.4M → $39.6M (-$5.83M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.52M |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$835K |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$671K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$575K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$463K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.16M |
| 2 |
PCM
Pinz Capital Management
New York
|
-$669K |
| 3 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$384K |
| 4 |
Morgan Stanley
New York
|
-$317K |
| 5 |
E
Ergoteles
New York
|
-$266K |
CLPT Hedge Fund Activity: Q3 2022 in Review
56 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q3 2022, worth a combined $39.6M — down 13% from $45.4M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new CLPT positions and 9 closed out — a net gain of 6 holders — while 18 added to existing stakes and 10 trimmed.
The largest buyer was BlackRock, adding an estimated $1.52M. The largest seller was Millennium Management, cutting an estimated $1.16M.
- 56 institutional investors held ClearPoint Neuro (CLPT) as of Q3 2022, up from 50 in Q2 2022.
- Funds reported $39.6M of ClearPoint Neuro stock for Q3 2022, down 13% quarter-over-quarter.
- 15 funds opened new ClearPoint Neuro positions in Q3 2022 and 9 closed out, a net change of +6 holders.
- The largest ClearPoint Neuro buyer in Q3 2022 was BlackRock, an estimated $1.52M added.
- The largest ClearPoint Neuro seller in Q3 2022 was Millennium Management, an estimated $1.16M sold.
Based on aggregated 13F filings for Q3 2022.